Thrombosis & Thromboembolism 2022

Advanced Thrombosis Medicine, Venous Thromboembolism (VTE), Anticoagulation, Pulmonary Embolism & Cardiovascular Prevention

Overview

Thrombosis & Thromboembolism 2022 is a comprehensive CME program from the North American Thrombosis Forum (NATF) that provides an evidence-based review of the latest advances in the prevention, diagnosis, and treatment of arterial and venous thrombotic disorders. Led by internationally recognized experts in thrombosis, cardiology, hematology, vascular medicine, and pulmonary vascular disease, the course explores evolving concepts in anticoagulation, atherosclerosis, venous thromboembolism (VTE), atrial fibrillation, pulmonary embolism (PE), peripheral arterial disease (PAD), cardio-oncology, and thrombosis-related complications.

The program integrates emerging research, guideline updates, novel therapies, cardiovascular prevention strategies, genetics, inflammation, COVID-associated thrombosis, and advanced interventions, helping clinicians optimize patient outcomes across a wide spectrum of thrombotic diseases.

Course Features

• Comprehensive CME Program
• Expert-Led Lectures
• Advanced Anticoagulation Updates
• Venous Thromboembolism (VTE) Education
• Pulmonary Embolism (PE) Management
• Atrial Fibrillation & Stroke Prevention
• Cardiovascular Prevention Strategies
• Genetics & Precision Medicine
• Cardio-Oncology & Thrombosis
• COVID-19 & Thrombotic Disease
• Pulmonary Hypertension Education
• Interactive Expert Discussions
• Evidence-Based Clinical Guidelines

Learning Objectives

Upon completion of this course, participants will be able to:

• Explain the pathophysiology of atherothrombosis and thromboembolic disease.
• Recognize the role of inflammation in thrombosis and cardiovascular disease.
• Apply modern stroke prevention strategies in atrial fibrillation.
• Determine appropriate anticoagulation duration for DVT and PE.
• Utilize advanced therapies including thrombolysis, catheter-directed intervention, and surgical embolectomy.
• Evaluate cardiovascular risk associated with diabetes and metabolic syndrome.
• Implement evidence-based prevention strategies for thrombotic disorders.
• Manage thrombosis during pregnancy and other high-risk clinical scenarios.

Major Topics Covered

Atherosclerosis & Cardiovascular Prevention

The course begins with an extensive review of modern cardiovascular prevention.

Topics Include

• Lipoprotein(a) [Lp(a)]
• LDL cholesterol management
• Apolipoprotein B (ApoB)
• Triglycerides (TG)
• ANGPTL3 inhibitors
• Inflammatory pathways

Faculty review emerging therapies targeting residual cardiovascular risk.

Inflammation & Thrombosis

A major focus of contemporary thrombosis medicine is the relationship between inflammation and clot formation.

Covered Topics

• Inflammatory mechanisms
• Atherosclerotic plaque instability
• Immune-mediated thrombosis
• Residual inflammatory risk

Participants learn how inflammatory pathways contribute to cardiovascular and thrombotic events.

Peripheral Arterial Disease (PAD)

Dedicated sessions focus on lower-extremity arterial disease.

Topics Include

• PAD diagnosis
• Limb preservation
• Antithrombotic therapy
• Cardiovascular risk reduction
• Prevention of major adverse limb events

Faculty discuss contemporary approaches to improving vascular outcomes.

Heart Failure & Thrombosis

The course explores the complex relationship between heart failure and thromboembolic disease.

Topics Include

• Heart failure with reduced ejection fraction (HFrEF)
• Heart failure with preserved ejection fraction (HFpEF)
• Mid-range ejection fraction
• Venous thromboembolism in heart failure
• Cardiac MRI applications

Participants review evolving therapies and diagnostic strategies.

SGLT2 & GLP-1 Therapies

Special sessions review emerging cardiovascular benefits of metabolic therapies.

Covered Topics

• SGLT2 inhibitors
• GLP-1 receptor agonists
• Cardiometabolic risk reduction
• Diabetes and cardiovascular disease
• Heart failure prevention

Faculty discuss landmark clinical trials influencing current practice.

Atrial Fibrillation & Stroke Prevention

The course provides comprehensive updates on thromboembolic prevention in atrial fibrillation.

Topics Include

• Stroke risk prediction
• Anticoagulation strategies
• Cardioversion management
• Catheter ablation anticoagulation
• Left atrial appendage closure (Watchman)

Participants review practical decision-making strategies for AF patients.

Anticoagulation Management

A major component of the program focuses on contemporary anticoagulation therapy.

Topics Include

• Direct oral anticoagulants (DOACs)
• Dose-reduced anticoagulation
• Arterial thrombosis management
• Venous thrombosis management
• Long-term anticoagulation

Faculty discuss balancing efficacy and bleeding risk.

Novel Anticoagulant Therapies

Emerging therapies are explored in dedicated sessions.

Covered Topics

• Factor XI inhibitors
• Factor XII inhibitors
• Future anticoagulation targets
• Next-generation antithrombotic agents

Participants gain insight into upcoming therapeutic innovations.

Venous Thromboembolism (VTE)

Extensive sessions review diagnosis and treatment of VTE.

Topics Include

• Deep vein thrombosis (DVT)
• Pulmonary embolism (PE)
• Risk stratification
• Secondary prevention
• Recurrent thrombosis

The course emphasizes guideline-based management.

Pulmonary Embolism Reperfusion Therapies

Advanced interventions for PE receive focused attention.

Covered Topics

• Catheter-directed therapy
• Mechanical thrombectomy
• Device-based PE treatment
• Systemic thrombolysis
• Surgical embolectomy

Faculty review indications, outcomes, and patient selection.

Pulmonary Hypertension & Thrombosis

Dedicated sessions focus on pulmonary vascular disease.

Topics Include

• Chronic thromboembolic pulmonary hypertension (CTEPH)
• Post-PE pulmonary hypertension
• Diagnostic evaluation
• Advanced treatment strategies

Participants learn modern approaches to managing chronic complications of thromboembolic disease.

COVID-19 & Thrombosis

The course reviews the impact of COVID-19 on coagulation and vascular health.

Topics Include

• COVID-associated thrombosis
• VTE prevention
• Hypercoagulability mechanisms
• Hospital-based anticoagulation strategies

Faculty discuss lessons learned during the pandemic.

Genetics & Precision Medicine

Modern thrombosis care increasingly incorporates genetic risk assessment.

Covered Topics

• Genetic predictors of VTE
• Clonal Hematopoiesis of Indeterminate Potential (CHIP)
• Personalized risk stratification
• Precision medicine applications

Participants review emerging evidence in thrombosis genetics.

Cancer-Associated Thrombosis

Specialized lectures address thrombotic complications in oncology.

Topics Include

• Cancer-associated thrombosis
• Prevention strategies
• Anticoagulation in cancer patients
• Cardio-oncology
• Treatment of VTE in malignancy

Faculty discuss complex management decisions in oncology patients.

Post-Thrombotic Syndrome

The course reviews long-term complications following venous thrombosis.

Topics Include

• Post-thrombotic syndrome (PTS)
• Chronic venous obstruction
• Endovascular intervention
• Medical therapy
• Long-term outcomes

Participants learn strategies to improve quality of life after VTE.

High-Risk Pregnancy & Thrombosis

Special sessions review thrombotic risk during pregnancy.

Topics Include

• Pregnancy-associated VTE
• Anticoagulation in pregnancy
• Maternal thrombosis prevention
• High-risk obstetric management

Faculty discuss evidence-based approaches to maternal care.

Health Equity & Racial Disparities

An important section focuses on disparities in thrombotic disease outcomes.

Topics Include

• Healthcare inequities
• Racial disparities in VTE
• Access to care
• Outcome differences

Participants explore strategies for improving equitable healthcare delivery.

Educational Features

✔ Comprehensive thrombosis and anticoagulation review

✔ Evidence-based VTE and PE management

✔ Advanced cardiovascular prevention updates

✔ Novel anticoagulant therapies

✔ Atrial fibrillation and stroke prevention

✔ Pulmonary hypertension and CTEPH education

✔ Cardio-oncology and cancer-associated thrombosis

✔ Genetics and precision medicine integration

✔ COVID-19 thrombosis updates

✔ Expert faculty and case-based learning

Who Should Attend?

This course is ideal for:

• Hematologists
• Cardiologists
• Vascular Medicine Specialists
• Internal Medicine Physicians
• Pulmonologists
• Critical Care Physicians
• Hospitalists
• Interventional Cardiologists
• Vascular Surgeons
• Nurse Practitioners
• Physician Assistants
• Fellows and Residents

Why This Course Stands Out

✔ Comprehensive review of arterial and venous thrombosis

✔ Covers both prevention and advanced intervention

✔ Features world-renowned thrombosis experts

✔ Integrates cardiology, hematology, and vascular medicine

✔ Strong emphasis on practical clinical application

✔ Reviews emerging therapies and future anticoagulants

✔ Includes COVID-19, genetics, and cardio-oncology

✔ Evidence-based and guideline-focused

✔ Valuable for both specialists and general clinicians

✔ Ideal for CME and clinical practice updates